1h
AllAfrica on MSNThe Global Fund Will Roll Out the Twice-Yearly Anti-HIV Jab - With or Without PEPFARThe major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...
The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine ...
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...
1d
The Manila Times on MSNConfidentiality clause under HIV and AIDS Policy ActDear PAO, I was clinically diagnosed with syphilis, a well-known sexually transmitted disease (STD) which leads to human ...
Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is ...
Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
Two decades of research indicates that sexual and gender minority people who believe in their community’s capacity to cope with and solve common problems are healthier.
The Equality Ohio Education Fund and Ohio Health Modernization Movement (OHMM) released an update last week to their 2024 ...
| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...
USAID’s promises to support lifesaving efforts are broken, putting millions in peril Source: ‘A bloodbath’: HIV field is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results